User profiles for Henry Kaplan
Henry Jerrold KaplanSaint Louis University Verified email at health.slu.edu Cited by 18470 |
[BOOK][B] Hodgkin's disease
HS Kaplan - 1980 - books.google.com
The malignant lymphomas comprise a broad spectrum of cell types and histologic patterns,
and their accurate diagnosis and classification constitutes one of the more difficult topics in …
and their accurate diagnosis and classification constitutes one of the more difficult topics in …
The radical radiotherapy of regionally localized Hodgkin's disease
HS Kaplan - Radiology, 1962 - pubs.rsna.org
Hodgkin's disease has long been a subject of controversy focused variously on its essential
nature (neoplasia vs. infection), its site of origin (unifocal vs. multicentric or systemic), its …
nature (neoplasia vs. infection), its site of origin (unifocal vs. multicentric or systemic), its …
Long-term culture of human bone marrow cells.
S Gartner, HS Kaplan - Proceedings of the National …, 1980 - National Acad Sciences
A method has been described for the long-term culture of human bone marrow cells in
liquid medium. Hematopoiesis, as measured by the production of granulocytic-macrophage …
liquid medium. Hematopoiesis, as measured by the production of granulocytic-macrophage …
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.
L Olsson, HS Kaplan - … of the National Academy of Sciences, 1980 - National Acad Sciences
We report the establishment of human-human hybridomas producing monoclonal antibody
of predefined antigenic specificity. The U-266 human myeloma cell line was incubated in the …
of predefined antigenic specificity. The U-266 human myeloma cell line was incubated in the …
Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications
RJ Carmel, HS Kaplan - Cancer, 1976 - Wiley Online Library
Abstract Analysis of the treatment and follow‐up records of 377 Hodgkin's disease patients
who received mantle irradiation but no planned chemotherapy reveals an overall …
who received mantle irradiation but no planned chemotherapy reveals an overall …
[HTML][HTML] Adaptive randomization of veliparib–carboplatin treatment in breast cancer
…, AJ Chien, AM Wallace, HG Kaplan… - … England Journal of …, 2016 - Mass Medical Soc
Background The genetic and clinical heterogeneity of breast cancer makes the identification
of effective therapies challenging. We designed I-SPY 2, a phase 2, multicenter, adaptively …
of effective therapies challenging. We designed I-SPY 2, a phase 2, multicenter, adaptively …
Evidence for an orderly progression in the spread of Hodgkin's disease
SA Rosenberg, HS Kaplan - Cancer research, 1966 - AACR
The sites of involvement of 100 unselected, untreated patients with Hodgkin's disease have
been studied. The extent of disease was determined by detailed clinical laboratory and …
been studied. The extent of disease was determined by detailed clinical laboratory and …
Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
HJ Kaplan, MA Leibole, T Tezel, TA Ferguson - Nature medicine, 1999 - nature.com
A principal cause of blindness is subretinal neovascularization associated with age-related
macular degeneration. Excised neovascular membranes from patients with age-related …
macular degeneration. Excised neovascular membranes from patients with age-related …
[HTML][HTML] Adaptive randomization of neratinib in early breast cancer
…, SY Chui, KA Kemmer, HG Kaplan… - … England Journal of …, 2016 - Mass Medical Soc
Background The heterogeneity of breast cancer makes identifying effective therapies challenging.
The I-SPY 2 trial, a multicenter, adaptive phase 2 trial of neoadjuvant therapy for high-…
The I-SPY 2 trial, a multicenter, adaptive phase 2 trial of neoadjuvant therapy for high-…
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization
…, Y Wang, S Kaliappan, HJ Kaplan… - The Journal of …, 2005 - journals.aai.org
Choroidal neovascularization (CNV), or choroidal angiogenesis, is the hallmark of age-related
macular degeneration and a leading cause of visual loss after age 55. The pathogenesis …
macular degeneration and a leading cause of visual loss after age 55. The pathogenesis …